THC Biomed Intl Ltd C.THC

Alternate Symbol(s): THCBF

Healthcare Cannabis

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).

CSE:THC - Post by User

THC Biomed Intl Ltd > THC (CA$0.09) is 97.9% Undervalued

<< Previous

Bullboard Posts

Next >>

Comment by SheerBolshevikon Oct 04, 2021 1:38pm

120 Views

Post# 33961440

RE:RE:THC (CA$0.09) is 97.9% Undervalued

Nonsensical projection
how did they arrive at this conclusion?

RamboOO7 wrote: They had to talk to JM before releasing stock projections like that. I always said THC KISS BISCUITS WILL BE THEIR GRAND SLAM PRODUCT TO BE RECOGNIZED AND ACCEPTED BY ALL PROVINCES. I SEE EXPANSION HAPPENING AFTER STOCK LIFTS OFF TO $4

Blendedman wrote: Currently on Simplywall.st:

THC (CA$0.09) is 97.9% Undervalued and trading below our estimate of fair value (CA$4.07)

Future Growth

How is THC Biomed Intl forecast to perform in the next 1 to 3 years?

105.1%

Forecasted annual earnings growth

Revenue vs Market: THC's revenue (85.7% per year) is forecast to grow faster than the Canadian market (6.3% per year).

Long Term Liabilities: THC's short term assets (CA$4.8M) exceed its long term liabilities (CA$2.1M).